Core Points - The company completed the placement and subscription matters on July 30, 2025, and August 5, 2025, respectively [1] - A total of 37.5245 million shares were placed, representing approximately 4.18% of the enlarged issued share capital after the subscription [1] - The placement was successfully executed at a price of HKD 9.13 per share to no fewer than six subscribers [1] - The subscription also involved 37.5245 million shares, which were issued to the seller, with net proceeds from the subscription amounting to approximately HKD 324 million [1]

配售事项的所有条件均已获达成，且配售事项已于2025年7月30日完成。合共3752.45万股配售股份(占 紧随认购事项完成后公司经扩大已发行股本约4.18%)已由配售代理按配售价每股配售股份9.13港元成功 配售予不少于六名承配人。 认购事项之所有条件已获达成，而认购事项已于2025年8月5日完成。合共3752.45万股认购股份(占紧随 认购事项完成后公司经扩大已发行股本约4.18%)已配发及发行予卖方。公司将从认购事项收取所得款项 净额约3.24亿港元。 智通财经APP讯，巨星传奇(06683)公布，配售事项及认购事项已分别于2025年7月30日及2025年8月5日 完成。 ...

Core Viewpoint - The company, 巨星传奇, has initiated a collaboration plan with 100 top international trend artists, featuring 周杰伦's 二次元 IP character "周同学" as the main focus, which is expected to enhance its market presence and drive sales growth [1] Group 1: Collaboration and Partnerships - 巨星传奇's collaboration plan includes top artists from China, the United States, and Thailand, aiming to create new artistic works and derivatives centered around the "周同学" IP [1] - The first results of this collaboration are set to be unveiled before 周杰伦's "嘉年华" concert in Wuhan in September, alongside a large "周同学艺术展" showcasing works from over 20 artists [1] - The company has entered into a strategic partnership with 杭州宇树科技, focusing on the development and commercialization of consumer-grade robots, particularly four-legged robotic dogs with social attributes [1] Group 2: Market Performance - Following the announcement, 巨星传奇's stock price increased by nearly 6%, with a current price of 13.98 HKD and a trading volume of 436 million HKD [1]

Group 1 - The core point of the article is that Giant Star Legend (06683) has initiated a collaboration plan with 100 top international trend artists, featuring Jay Chou's official two-dimensional IP character "Zhou Tongxue" as the main focus [1] - The first batch of collaborative works is set to be unveiled before Jay Chou's "Carnival" concert in Wuhan in September, along with a large-scale "Zhou Tongxue Art Exhibition" showcasing works from over 20 artists [1] - The company has established a strategic partnership with Hangzhou Yushu Technology, focusing on the development and commercialization of consumer-grade robots, particularly four-legged robotic dogs with social attributes [1] Group 2 - The collaboration aims to explore the commercial value of intelligent robots in scenarios such as concerts and performances [1] - The stock price of Giant Star Legend has seen a significant increase, rising nearly 6% and currently trading at 13.98 HKD with a transaction volume of 436 million HKD [1]

Core Insights - The company, Giant Star Legend, has launched a collaboration plan with 100 top international trend artists, marking a significant upgrade in its international IP strategy [1] - The core IP, "Zhou Classmate," associated with Jay Chou, will be the focal point of this initiative, with artists from various countries creating new artworks and derivatives [1][2] - The collaboration aims to enhance the cultural connotation of "Zhou Classmate" through diverse artistic contributions, ensuring the IP's longevity and relevance [1] Company Strategy - Giant Star Legend is taking a crucial step in internationalizing its IP operations, aiming to build a global pool of artist resources and strengthen the development of original IP and derivative content [1] - The company has established a dual-track selection mechanism combining data intelligence and expert reviews to identify artists with commercial potential and artistic value [1] - The focus is on precision co-creation rather than sheer quantity, ensuring that each artist adds unique value to the "Zhou Classmate" IP [1] Market Context - The collaboration is seen as a strategic move to create an exclusive artistic ecosystem, similar to industry leaders like Pop Mart, which has signed over 200 top artists globally [2] - The first major event will be a "Zhou Classmate Art Exhibition" in Wuhan, coinciding with Jay Chou's concert, enhancing the integration of culture, tourism, and commerce [2] - Since its launch in 2019, the "Zhou Classmate" IP has generated over 1 billion yuan in sales through various innovative models, establishing itself as one of the most commercially valuable IPs in the market [2] Industry Implications - The upcoming art exhibition is being closely watched for its market response, as Giant Star Legend aims to build a comprehensive ecosystem integrating entertainment, consumption, technology, and culture [3] - Jay Chou's status as a national music icon provides a strong emotional foundation for the IP, which has the potential to become a valuable sentimental asset [3] - Through refined operations and derivative development, the IP is expected to reach beyond its fan base into the broader consumer market, creating sustainable brand assets and commercial returns [3]

Core Viewpoint - The company, 巨星传奇, has launched a collaboration plan with 100 international top trend artists, focusing on its core IP, 周同学, to enhance its international IP strategy and expand creative boundaries through diverse artistic contributions [1][2]. Group 1: Collaboration and Strategy - The collaboration aims to create new artworks and derivatives around the 周同学 IP, leveraging the unique perspectives of artists from various cultural backgrounds [1]. - The company has established a dual-track selection mechanism combining data intelligence and expert review to identify artists with commercial potential and artistic value [1][2]. - The collaboration is not merely about quantity but aims for "precise co-creation" to ensure each artist adds differentiated value to the 周同学 IP [2]. Group 2: Market Impact and Future Plans - The first batch of collaborative works is set to debut before the 周杰伦 "嘉年华" concert in Wuhan in September 2025, with a large-scale art exhibition showcasing works from over 20 artists [2]. - The initiative is seen as a move to build a unique artistic creation ecosystem, similar to industry leaders like 泡泡玛特, which has signed over 200 top artists [2]. - The company has achieved over 1 billion yuan in sales from authorized co-branded products since the launch of the 周同学 IP in 2019, indicating its significant commercial value [3]. Group 3: Broader Industry Context - The collaboration is expected to enhance the artistic value of the IP and explore new pathways for the globalization of Chinese original IP [3]. - The emotional value provided by the IP is crucial, as interest-driven consumption trends are becoming increasingly important [3]. - The potential for 周同学 to become a long-term brand asset and sustainable commercial return is highlighted through refined operations and derivative development [3].

Group 1 - On August 1, the Hong Kong stock market saw a net inflow of 12.207 billion HKD from northbound trading, with 5.575 billion HKD from the Shanghai Stock Connect and 6.632 billion HKD from the Shenzhen Stock Connect [2] - The most bought stocks included the Tracker Fund of Hong Kong (02800), Hang Seng China Enterprises (02828), and Xiaomi Group-W (01810), while the most sold stocks were Innovent Biologics (01801), Alibaba-W (09988), and SMIC (00981) [2][8] - Xiaomi Group-W reported over 30,000 vehicle deliveries in July, attributed to increased production capacity, with expectations of 400,000 to 500,000 vehicle sales by 2025 [6] Group 2 - In the technology sector, Tencent (00700), Meituan-W (03690), and Kuaishou-W (01024) saw net inflows of 8.36 billion, 7.66 billion, and 2.02 billion HKD respectively, while Alibaba-W faced a net outflow of 2.02 billion HKD [7] - InnoCare Pharma (02577) received a net inflow of 3.63 billion HKD after being listed as a partner by NVIDIA for its 800V DC power architecture, which is designed for AI data centers [7] - The overall sentiment in the Hong Kong market remains positive, with expectations of a structural uptrend driven by improving fundamentals and policy outlook [6][7]

Core Viewpoint - On August 1, InnoCare Pharma made its debut on the Hong Kong Stock Connect active trading list, marking its first appearance in the past month, with significant trading volume and a notable price increase [1] Trading Activity Summary - The total trading volume of active stocks on the Hong Kong Stock Connect reached 38.767 billion HKD, accounting for 29.03% of the total trading amount on that day, with a net buying amount of 9.016 billion HKD [1] - Tencent Holdings led the trading volume with 5.412 billion HKD, followed closely by InnoCare Pharma and Alibaba-W, with trading amounts of 4.391 billion HKD and 4.390 billion HKD respectively [1] Stock Performance Summary - InnoCare Pharma recorded a trading volume of 4.391 billion HKD on August 1, with a net buying amount of 0.364 billion HKD, and its stock price surged by 30.91% on that day [1] - The stocks with the highest frequency of appearance on the active trading list over the past month were Alibaba-W and Tencent Holdings, each appearing 23 times, indicating strong interest from Hong Kong Stock Connect investors [1]

Market Overview - On August 1, the Hang Seng Index fell by 1.07%, with southbound trading totaling HKD 1,335.36 billion, comprising HKD 728.72 billion in buying and HKD 606.64 billion in selling, resulting in a net buying amount of HKD 122.07 billion [1] Southbound Trading Details - Southbound trading through the Stock Connect (Shenzhen) recorded a total trading amount of HKD 507.42 billion, with net buying of HKD 66.32 billion, while the Stock Connect (Shanghai) had a total trading amount of HKD 827.94 billion and net buying of HKD 55.75 billion [1] - The most actively traded stock by southbound funds was Tencent Holdings, with a total trading amount of HKD 54.12 billion, followed by InnoCare Pharma and Alibaba Group, with trading amounts of HKD 43.91 billion and HKD 43.90 billion, respectively [1] Net Buying and Selling Analysis - The top net buying stocks included the Tracker Fund of Hong Kong with a net buying amount of HKD 37.44 billion, followed by Hang Seng China Enterprises with HKD 17.20 billion and Xiaomi Group with HKD 10.99 billion [1] - The stock with the highest net selling was Innovent Biologics, with a net selling amount of HKD 4.02 billion, while Alibaba Group and SMIC experienced net selling of HKD 2.02 billion and HKD 1.77 billion, respectively [1] Continuous Net Buying Stocks - Among the stocks that have seen continuous net buying for more than three days, Tencent Holdings, Xiaomi Group, and Meituan had the longest streaks, with 7 days, 6 days, and 3 days of net buying, respectively [2] - The highest net buying amounts during this period were for Xiaomi Group at HKD 41.36 billion, followed by Tencent Holdings at HKD 35.42 billion and Meituan at HKD 26.12 billion [2] Active Stocks on August 1 - The following stocks were highlighted for their trading activity on August 1: - Tracker Fund of Hong Kong: Total trading amount HKD 376.30 million, net buying HKD 374.44 million, price change -1.11% - Hang Seng China Enterprises: Total trading amount HKD 221.46 million, net buying HKD 171.97 million, price change -0.95% - Xiaomi Group: Total trading amount HKD 399.61 million, net buying HKD 109.92 million, price change +0.47% - Tencent Holdings: Total trading amount HKD 541.21 million, net buying HKD 83.62 million, price change -2.73% [2]

Group 1 - On August 1, the Hong Kong stock market saw a net inflow of 12.207 billion HKD from northbound trading, with 5.575 billion HKD from the Shanghai Stock Connect and 6.632 billion HKD from the Shenzhen Stock Connect [2] - The most bought stocks included the Tracker Fund of Hong Kong (02800), Hang Seng China Enterprises (02828), and Xiaomi Group-W (01810), while the most sold stocks were Innovent Biologics (01801), Alibaba-W (09988), and SMIC (00981) [2] - The Tracker Fund of Hong Kong received a net inflow of 37.44 billion HKD, Hang Seng China Enterprises received 17.19 billion HKD, and Southern Hang Seng Technology (03033) received 8.55 billion HKD [5] Group 2 - Xiaomi Group-W (01810) saw a net inflow of 8.55 billion HKD, with the chairman announcing that July's car deliveries exceeded 30,000 units due to increased production capacity [6] - Tencent (00700), Meituan-W (03690), and Kuaishou-W (01024) received net inflows of 8.36 billion HKD, 7.66 billion HKD, and 2.02 billion HKD respectively, while Alibaba-W (09988) faced a net outflow of 2.02 billion HKD [6] - Innovent Biologics (02577) received a net inflow of 3.63 billion HKD after being listed as a partner by NVIDIA for its 800V direct current power architecture [7] Group 3 - Guotai Junan International (01788) experienced a net outflow of 48.99 million HKD amid the implementation of the stablecoin regulatory framework in Hong Kong [8] - Other stocks that saw net inflows included CSPC Pharmaceutical Group (01093) with 2.52 billion HKD and Giant Legend (06683) with 6.55 million HKD, while Innovent Biologics (01801) and SMIC (00981) faced net outflows of 4.02 billion HKD and 1.77 billion HKD respectively [8]